Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma.
Uryu H, Mishima Y, Tsuyama N, Yokoyama M, Nishimura N, Fukuta T, Shirouchi Y, Okabe T, Inoue N, Takeuchi K, Terui Y. Uryu H, et al. Among authors: okabe t. Leuk Lymphoma. 2021 Sep;62(9):2141-2150. doi: 10.1080/10428194.2021.1901091. Epub 2021 Mar 21. Leuk Lymphoma. 2021. PMID: 33749498
The clonal evolution during long-term clinical course of multiple myeloma.
Mishima Y, Mishima Y, Shirouchi Y, Nishimura N, Yokoyama M, Okabe T, Inoue N, Uryu H, Fukuta T, Hatake K, Terui Y. Mishima Y, et al. Among authors: okabe t. Int J Hematol. 2021 Feb;113(2):279-284. doi: 10.1007/s12185-020-02979-7. Epub 2020 Aug 30. Int J Hematol. 2021. PMID: 32864713
The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patients.
Ogihara K, Kikuchi E, Shigeta K, Okabe T, Hattori S, Yamashita R, Yoshimine S, Shirotake S, Nakazawa R, Matsumoto K, Mizuno R, Hara S, Oyama M, Masuda T, Niwakawa M, Oya M. Ogihara K, et al. Among authors: okabe t. Urol Oncol. 2020 Jun;38(6):602.e1-602.e10. doi: 10.1016/j.urolonc.2020.02.005. Epub 2020 Mar 2. Urol Oncol. 2020. PMID: 32139290
A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis-assisted transurethral resection involving orally administered 5-aminolevulinic acid.
Watanabe K, Shirotake S, Umezawa Y, Takahashi T, Yamanaka T, L Santo N, Okabe T, Kaneko G, Sano K, Yasuda M, Kanao K, Oyama M, Nishimoto K. Watanabe K, et al. Among authors: okabe t. IJU Case Rep. 2019 Sep 13;2(6):313-316. doi: 10.1002/iju5.12109. eCollection 2019 Nov. IJU Case Rep. 2019. PMID: 32743447 Free PMC article.
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone.
Kanao K, Takahashi T, Umezawa Y, Okabe T, Kaneko G, Shirotake S, Nishimoto K, Oyama M. Kanao K, et al. Among authors: okabe t. PLoS One. 2022 Oct 20;17(10):e0276081. doi: 10.1371/journal.pone.0276081. eCollection 2022. PLoS One. 2022. PMID: 36264927 Free PMC article.
1,298 results